The clinical observations in patients with PHTS with PTEN-R173 variants mirror the phenotypes of Pten+/R173C mice; although most patients display neurodevelopmental phenotypes early on in life, they develop malignant cancers at a low frequency. This evidence concerns the gene PTEN and cancer.